press release – price-sensitive

PRICE-SENSITIVE | NON PRICE-SENSITIVE

  • ARTERRA BIOSCIENCE ANNOUNCES THE SIGNING OF THE ADDENDUM TO THE VITALAB SHAREHOLDERS’ AGREEMENT

    ARTERRA BIOSCIENCE ANNOUNCES THE SIGNING OF THE ADDENDUM TO THE VITALAB SHAREHOLDERS' AGREEMENT
    Go to the press release

  • THE BOARD OF DIRECTORS HAS APPROVED THE HALF-YEARLY REPORT AS OF 30 JUNE 2025

    THE BOARD OF DIRECTORS HAS APPROVED THE HALF-YEARLY REPORT AS OF 30 JUNE 2025
    Go to the press release

  • SUBSTANTIAL CHANGE IN OWNERSHIP STRUCTURE

    SUBSTANTIAL CHANGE IN OWNERSHIP STRUCTURE
    Go to the press release

  • ARTERRA BIOSCIENCE S.P.A. HAS SOLD ITS ENTIRE STAKE IN THE SHARE CAPITAL OF LONGEVITY BIOSCIENCE S.R.L. EQUAL TO € 43,999.17

    ARTERRA BIOSCIENCE S.P.A. HAS SOLD ITS ENTIRE STAKE IN THE SHARE CAPITAL OF LONGEVITY BIOSCIENCE S.R.L. EQUAL TO € 43,999.17
    Go to the press release

  • ARTERRA BIOSCIENCE S.P.A. HAS SOLD ITS ENTIRE STAKE IN THE SHARE CAPITAL OF LONGEVITY BIOSCIENCE S.R.L.

    ARTERRA BIOSCIENCE S.P.A. HAS SOLD ITS ENTIRE STAKE IN THE SHARE CAPITAL OF LONGEVITY BIOSCIENCE S.R.L.
    Go to the press release

  • TURNOVER AT JUNE 30, 2025, APPROXIMATELY 2.6 MILLION EUROS

    TURNOVER AT JUNE 30, 2025, APPROXIMATELY 2.6 MILLION EUROS
    Go to the press release

  • SUBSTANTIAL CHANGE IN OWNERSHIP STRUCTURE

    SUBSTANTIAL CHANGE IN OWNERSHIP STRUCTURE
    Go to the press release

  • ARTERRA BIOSCIENCE S.P.A. PARTICIPATES IN THE “FINANCIAL GALÀ” EVENT ORGANIZED BY INTEGRAE SIM ON 19 JUNE 2025

    ARTERRA BIOSCIENCE S.P.A. PARTICIPATES IN THE “FINANCIAL GALÀ” EVENT ORGANIZED BY INTEGRAE SIM ON 19 JUNE 2025
    Go to the press release

  • FINANCING AND GRANTING OF INCENTIVES FOR THE “SmartLAB 2.0” PROJECT WORTH APPROXIMATELY €3 MILLION

    FINANCING AND GRANTING OF INCENTIVES FOR THE “SmartLAB 2.0” PROJECT WORTH APPROXIMATELY €3 MILLION
    Go to the press release

  • TURNOVER AS OF MARCH 31, 2025 EQUAL TO APPROXIMATELY 1.3 MILLION EUROS

    TURNOVER AS OF MARCH 31, 2025 EQUAL TO APPROXIMATELY 1.3 MILLION EUROS
    Go to the press release